VitroScreen m-Dermis (scaffold free organoid) is produced by human primary dermal fibroblasts and with donors of different age : it has shown interesting features during 21 days in culture conditions.
By precisely mimicking ECM production in vivo, the micro-dermis model resulted to be an unique and innovative tool for active ingredients screening on dermal matrix deposition and remodeling by VitroScreen Multiple Endpoints Approach that includes also 3D imaging techniques.
Marisa Méloni
marisa.meloni@vitroscreen.com
Via Mosé Bianchi,103
20149 Milano
LIVE & HYBRID All you need to know about preclinical and clinical testing is at…
Abstract Background Oxidative stress is a significant factor in skin aging and pigmentation, which can be precipitated…
Remote prescribing of cosmetic injectables is set to be banned within weeks in a landmark…
